Cargando…

Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19

The medical care of immunocompromised patients with COVID-19 infection causes major hurdles in the management of these patients in clinical practice. However, poor responses to vaccinations in patients with oncological or autoimmune diseases require rapid action and effective care in this fragile pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klank, David, Claus, Bernd, Bergner, Raoul, Paschka, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786569/ https://www.ncbi.nlm.nih.gov/pubmed/36557743 http://dx.doi.org/10.3390/microorganisms10122490

Ejemplares similares

Monoclonal Antibodies for the Prevention and Treatment of COVID-19 Disease in Patients With Hematological Malignancies: Two Case Reports and a Literature Review
por: Klank, David, et al.
Publicado: (2021)

Histological Findings in Kidney Biopsies of Patients with Monoclonal Gammopathy—Always a Surprise
por: Klank, David, et al.
Publicado: (2022)

Use of monoclonal antibody therapy in hematologic patients with mild‐to‐moderate COVID‐19: A retrospective single‐center experience
por: Amanam, Idoroenyi, et al.
Publicado: (2023)

Standing-up COVID-19 monoclonal antibody infusion centers: Infection prevention and control
por: Brewer, Brooke, et al.
Publicado: (2023)

Real-world Experience of Sotrovimab in High-risk, Immunocompromised COVID-19 Patients
por: Birk, Navina K, et al.
Publicado: (2022)

Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant
por: O’Horo, John C., et al.
Publicado: (2022)

Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort
por: Calderón-Parra, Jorge, et al.
Publicado: (2023)

465. Use of Monoclonal Antibodies for COVID-19 in Solid Organ Transplant Recipients: A Single-Center Experience
por: Gomez, Keven, et al.
Publicado: (2023)

Monoclonal Antibody Therapy for COVID-19: A Public Health Perspective From Arkansas
por: Kothari, Atul, et al.
Publicado: (2022)

Breakthrough Gastrointestinal COVID-19 and Intrahost Evolution Consequent to Combination Monoclonal Antibody Prophylaxis( )
por: Beddingfield, Brandon J, et al.
Publicado: (2022)

Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment
por: Thümmler, Laura, et al.
Publicado: (2022)

Use of Monoclonal Antibody Therapy in Hematologic Patients with Mild-to-Moderate COVID-19: A Retrospective Single-Center Experience
por: Amanam, Idoroenyi, et al.
Publicado: (2021)

Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective Study
por: Bavaro, Davide Fiore, et al.
Publicado: (2023)

Analysis of Antibody Responses After COVID-19 Vaccination in Liver Transplant Recipients: A Single-Center Study
por: Oh, Young Ju, et al.
Publicado: (2023)

Monoclonal antibodies as treatment for COVID-19
por: Medina Gamero, A., et al.
Publicado: (2022)

Cardiac Intensive Care Unit Admissions during COVID-19 Pandemic—A Single Center Experience
por: Yalamanchi, Radhapriya, et al.
Publicado: (2020)

Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with COVID-19: A Single Center Experience
por: Latief, Muzamil, et al.
Publicado: (2023)

Experience of Rwanda on COVID-19 Case Management: From Uncertainties to the Era of Neutralizing Monoclonal Antibodies
por: Nkeshimana, Menelas, et al.
Publicado: (2022)

Monoclonal Antibodies for Early Treatment of COVID-19 in a World of Evolving SARS-CoV-2 Mutations and Variants
por: Pogue, Jason M, et al.
Publicado: (2021)

A cocktail of antibodies for COVID-19 therapy
por: Matthews, Dean B.
Publicado: (2020)

Neutralizing antibody response in mild COVID-19
por: van der Heide, Verena
Publicado: (2020)

Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience
por: Cattaneo, D., et al.
Publicado: (2021)

Cross-reactive Antibody Response to mRNA SARS-CoV-2 Vaccine After Recent COVID-19-Specific Monoclonal Antibody Therapy
por: Schultz-Cherry, Stacey, et al.
Publicado: (2021)

Real-world experience of monoclonal antibodies in mild-to-moderate COVID-19 patients at a tertiary care center
por: Marwah, Vikas, et al.
Publicado: (2023)

Vanderbilt University Medical Center Ambulatory Teleneurology COVID-19 Experience
por: Harper, Kelly, et al.
Publicado: (2021)

Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies
por: Jary, Aude, et al.
Publicado: (2022)

Use of the Monoclonal Antibody Regdanvimab to Treat Patients Hospitalized with COVID-19: Real-World Data during the Delta Variant Predominance
por: Kwak, Yee Gyung, et al.
Publicado: (2022)

Neutralizing monoclonal antibodies for treatment of COVID-19
por: Taylor, Peter C., et al.
Publicado: (2021)

Tackling COVID-19 with neutralizing monoclonal antibodies
por: Corti, Davide, et al.
Publicado: (2021)

Tackling COVID-19 with neutralizing monoclonal antibodies
por: Corti, Davide, et al.
Publicado: (2021)

The Relevance of Monoclonal Antibodies in the Treatment of COVID-19
por: Torrente-López, Anabel, et al.
Publicado: (2021)

Engineering monoclonal antibodies for COVID-19 prophylaxis
por: Izadpanah, Amin, et al.
Publicado: (2022)

Surveillance of Close Contacts and Implications of Pediatric Patients with COVID-19–Experiences from a Single Residential Treatment Center
por: Baek, Yae Jee, et al.
Publicado: (2022)

The Higher Incidence of COVID-19 in Patients With Non-Tuberculous Mycobacterial Pulmonary Disease: A Single Center Experience in Korea
por: Kim, Sang Hyuk, et al.
Publicado: (2022)

549. Monoclonal Antibody Therapy for COVID-19 Infection in Michigan: The Flint Experience
por: Younas, Mariam, et al.
Publicado: (2021)

COVID-19 vaccination in immunocompromised patients
por: Sonani, Bhavin, et al.
Publicado: (2021)

COVID-19 in immunocompromised children and adolescents
por: Kwak, Byung Ok, et al.
Publicado: (2023)

War on Waste: Challenges and Experiences in COVID-19 Waste Management
por: Gowda, Naveen R., et al.
Publicado: (2021)

Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany
por: Koehler, Johanna, et al.
Publicado: (2021)

Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic
por: Bariola, J Ryan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mf257mpfsmf2p6u4d0946qkpao